news
Machine learning (ML) presents a promising opportunity to revolutionize early…
25 July 2023 | By Izzy Wood (Drug Target Review)
Machine learning (ML) presents a promising opportunity to revolutionize early cancer detection in primary care, addressing the challenges associated with diagnostic errors and improving patient outcomes. The potential of ML in this field is highlighted in a recent paper published in Oncoscience